EUVIMEDEUVIMED entdecken
Crossref

Two‐Phase Electrosynthesis of Dihydroxycoumestans: Discovery of a New Scaffold for Topoisomerase I Poison

Yue-Xi Chen, Shanchao Wu, Xiang Shen, Dong-Fang Xu, Qian Wang, Su-Hui Ji, Huajian Zhu, Ge Wu, Chunquan Sheng, Yun-Rui Cai iD

Chemistry – A European Journal · 2024

DOI: 10.1002/chem.202401400 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – A European Journal, 2024. Verfasst von Yue-Xi Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, People's Republic of China. Hauptthemen laut MEDLINE: Topoisomerase I Inhibitors, DNA Topoisomerases, Type I, Antineoplastic Agents, Coumarins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coumestan represents a biologically relevant structural motif distributed in a number of natural products, and the rapid construction of related derivatives as well as the characterization of targets would accelerate lead compound discovery in medicinal chemistry. In this work, a general and scalable approach to 8,9‐dihydroxycoumestans via two‐electrode constant current electrolysis was developed. The application of a two‐phase (aqueous/organic) system plays a crucial role for success, protecting the sensitive o ‐benzoquinone intermediates from over‐oxidation. Based on the structurally diverse products, a primary SAR study on coumestan scaffold was completed, and compound 3 r exhibited potent antiproliferative activities and a robust topoisomerase I (Top1) inhibitory activity. Further mechanism studies demonstrates that compound 3 r was a novel Top1 poison, which might open an avenue for the development of Top1‐targeted antitumor agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Topoisomerase I InhibitorsDNA Topoisomerases, Type IAntineoplastic AgentsCoumarinsHumansStructure-Activity RelationshipCell Line, TumorCell ProliferationOxidation-ReductionUmbelliferonesDrug Screening Assays, Antitumor

Stichwörter der Autor:innen

antitumorcoumestano-benzoquinonetopoisomerase Itwo-phase electrosynthesis

Substanzen

Topoisomerase I InhibitorsDNA Topoisomerases, Type IAntineoplastic AgentsCoumarinsUmbelliferones

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, People's Republic of China.
  • Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai, 200433, People's Republic of China.
  • Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, 310015, Zhejiang Province, China.

ORCID-Profile: Yun-Rui Cai

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Chen, Y. X., Wu, S., Shen, X., Xu, D. F., Wang, Q., Ji, S. H., Zhu, H., Wu, G., Sheng, C., & Cai, Y. R. (2024). Two‐Phase Electrosynthesis of Dihydroxycoumestans: Discovery of a New Scaffold for Topoisomerase I Poison. Chemistry – A European Journal. https://doi.org/10.1002/chem.202401400

Vancouver

Chen YX, Wu S, Shen X, Xu DF, Wang Q, Ji SH, et al. Two‐Phase Electrosynthesis of Dihydroxycoumestans: Discovery of a New Scaffold for Topoisomerase I Poison. Chemistry – A European Journal. 2024. doi:10.1002/chem.202401400

BibTeX
@article{Chen2024,
  author = {Chen, Yue-Xi and Wu, Shanchao and Shen, Xiang and Xu, Dong-Fang and Wang, Qian and Ji, Su-Hui and Zhu, Huajian and Wu, Ge and Sheng, Chunquan and Cai, Yun-Rui},
  title = {Two‐Phase Electrosynthesis of Dihydroxycoumestans: Discovery of a New Scaffold for Topoisomerase I Poison},
  journal = {Chemistry – A European Journal},
  year = {2024},
  doi = {10.1002/chem.202401400}
}
Kostenlos starten →